Melanomas with mutations in the NRAS gene, known as NRASMUT melanomas, account for nearly 30% of all cases. These tumors are particularly aggressive and often resist therapy. Current treatments ...

We assessed six cell lines known to harbor Nras gene mutations using our multicolor multiplex assay. Two of the cell lines, MOLT-4 and PA-1, contain mutations in codon 12, while the remaining four ...

Caris Life Sciences has collected $168 million in new funding to support the growth of its precision medicine platforms, ...